TipRanks
Vir Biotechnology (VIR)
NASDAQ:VIR
US Market
VIR
Vir Biotechnology
RESEARCH TOOLSreports
Want to see VIR full AI Analyst Report?

Vir Biotechnology (VIR) Income Statement

1,561 Followers

Vir Biotechnology Income Statement

Last quarter (Q2 2026), Vir Biotechnology's total revenue was $238.95M, an increase of 19582.54% from the same quarter last year. In Q2, Vir Biotechnology's net income was $80.08M. See Vir Biotechnology’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 68.56M$ 74.20M$ 86.18M$ 1.62B$ 1.10B
Gross Profit
$ 56.85M$ 58.80M$ 63.96M$ 1.45B$ 1.02B
Operating Expenses
$ 524.87M$ 582.22M$ 724.97M$ 620.92M$ 602.99M
Depreciation and Amortization
$ 11.68M$ 14.56M$ 19.45M$ 15.49M$ 11.98M
EBITDA
$ -456.34M$ -508.86M$ -641.55M$ 848.56M$ 432.73M
Operating Income
$ -468.02M$ -523.42M$ -661.00M$ 833.07M$ 420.75M
Other Income/Expenses
$ 30.25M$ 316.00K$ 32.81M$ -78.79M$ 129.05M
Pretax Income
$ -437.77M$ -523.11M$ -628.19M$ 754.28M$ 549.80M
Net Income
$ -437.99M$ -521.96M$ -615.06M$ 515.84M$ 528.58M
Per Share Metrics
Basic EPS
$ -3.16$ -3.83$ -4.59$ 3.89$ 4.07
Diluted EPS
$ -3.16$ -3.83$ -4.59$ 3.83$ 3.96
Weighted Average Shares Outstanding
 138.52M 136.25M 134.13M 132.61M 129.88M
Weighted Average Shares Outstanding (Diluted)
 138.52M 136.25M 134.13M 134.81M 133.44M
Currency in USD

Vir Biotechnology Earnings and Revenue History